P
US9139746B2ActiveUtilityPatentIndex 52

Phase change ink compositions comprising mixtures of ester of tartaric acid and ester of citric acid as amorphous materials

Assignee: XEROX CORPPriority: Jun 4, 2013Filed: Jun 4, 2013Granted: Sep 22, 2015
Est. expiryJun 4, 2033(~6.9 yrs left)· nominal 20-yr term from priority
Inventors:MORIMITSU KENTAROGOREDEMA ADELACHOPRA NAVEENVANBESIEN DARYL W
C09D 11/102C09D 11/38C09D 11/34
52
PatentIndex Score
0
Cited by
34
References
7
Claims

Abstract

The disclosure provides phase change ink compositions comprising an amorphous material comprising mixtures of ester of tartaric acid and ester of citric acid.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A phase change ink comprising:
 a crystalline component; and 
 an amorphous component material comprising a mixture of dicyclohexyl L-tartrate and tricyclohexyl citrate; 
 wherein the mol % ratio of the ester tartaric acid to the ester citric acid is from about 50:50 to about 75:25; wherein the amorphous component material has a glass transition temperature of from about −11° C. to about −14° C. 
 
     
     
       2. The phase change ink of  claim 1 , wherein the amorphous component material is present in an amount of from about 5 percent to about 40 percent by weight of the total weight of the phase change ink. 
     
     
       3. The phase change ink of  claim 1 , wherein the crystalline/amorphous ratio is from about 60/40 to about 95/5. 
     
     
       4. The phase change ink of  claim 1  further comprising a colorant selected from the group consisting of a pigment, dye and mixtures thereof. 
     
     
       5. The phase change ink of  claim 1  having a viscosity of less than 22 cps at a temperature of about 140° C. 
     
     
       6. The phase change ink of  claim 1  having a viscosity of greater than 10 6  cps at room temperature. 
     
     
       7. The phase change ink of  claim 1  having a jetting temperature of from about 100 to about 140° C.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.